Search company, investor...
HemoShear Therapeutics company logo

HemoShear Therapeutics

hemoshear.com

Founded Year

2008

Stage

Series A | Alive

Total Raised

$66.31M

Last Raised

$40M | 2 yrs ago

About HemoShear Therapeutics

HemoShear Therapeutics discovers biological targets and advances drug programs to treat metabolic disorders with significant unmet patient need. Its proprietary drug discovery platform, REVEAL-TX, enables the company to create best-in-class, biological human disease models to uncover and explain the underlying mechanisms of disease, translate those discoveries into drug candidates, and predict which drug candidates will treat patients successfully.

Headquarters Location

501 Locust Avenue Suite 301

Charlottesville, Virginia, 22902,

United States

434-872-0196

Missing: HemoShear Therapeutics's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: HemoShear Therapeutics's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing HemoShear Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

HemoShear Therapeutics is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

838 items

HemoShear Therapeutics Patents

HemoShear Therapeutics has filed 13 patents.

The 3 most popular patent topics include:

  • Transcription factors
  • Cell biology
  • Clusters of differentiation
patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/18/2019

7/13/2021

Transcription factors, Clusters of differentiation, Fluid dynamics, Biotechnology, Cell biology

Grant

Application Date

12/18/2019

Grant Date

7/13/2021

Title

Related Topics

Transcription factors, Clusters of differentiation, Fluid dynamics, Biotechnology, Cell biology

Status

Grant

Latest HemoShear Therapeutics News

07:30 EDT HemoShear Therapeutics to Participate in SVB Leerink Securities Biopharma Private Company Connect

Oct 18, 2022

News provided by Share this article Share this article CHARLOTTESVILLE, Oct. 18, 2022 /PRNewswire/ -- HemoShear Therapeutics, Inc., a privately held clinical stage biotechnology company, today announced that it will participate in SVB Leerink Biopharma Private Company Connect being held virtually October 26-27. Investor one-on-one meetings with the HemoShear management team may be requested through SVB Securities. About HemoShear Therapeutics HemoShear Therapeutics, Inc. is a privately held clinical stage company developing treatments for rare diseases with significant unmet patient need. HemoShear's drug discovery platform, REVEAL-Tx™, enables the Company's scientists to create best-in-class, biologically relevant human disease models to uncover the underlying mechanisms of disease, translate those discoveries into drug targets, and select candidates that may treat patients successfully. HemoShear completed an exclusive partnership identifying two novel therapeutic approaches in nonalcoholic steatohepatitis (NASH) for Takeda  in 2021. The Company has ongoing collaborations with Takeda in a rare liver disease and with Horizon Therapeutics  in gout. For more information visit www.HemoShear.com . SOURCE HemoShear Therapeutics

HemoShear Therapeutics Frequently Asked Questions (FAQ)

  • When was HemoShear Therapeutics founded?

    HemoShear Therapeutics was founded in 2008.

  • Where is HemoShear Therapeutics's headquarters?

    HemoShear Therapeutics's headquarters is located at 501 Locust Avenue, Charlottesville.

  • What is HemoShear Therapeutics's latest funding round?

    HemoShear Therapeutics's latest funding round is Series A.

  • How much did HemoShear Therapeutics raise?

    HemoShear Therapeutics raised a total of $66.31M.

  • Who are the investors of HemoShear Therapeutics?

    Investors of HemoShear Therapeutics include MedCap Advisors, Janus Henderson Investors, Suvretta Capital Management, Adage Capital Management, Paycheck Protection Program and 6 more.

  • Who are HemoShear Therapeutics's competitors?

    Competitors of HemoShear Therapeutics include SynCardia Systems, Bioness, FzioMed, Mercator MedSystems, Elastagen and 9 more.

Compare HemoShear Therapeutics to Competitors

F
FluimediX

FluimediX is in the process of developing the NanoCycler device. The NanoCycler is a tabletop device designed to accept a disposable polymer cartridge, in which a number of biochemical reactions are performed on a human saliva sample. The NanoCycler will deliver an identification of the presence of - respectively lack of - a number of genetic mutations; the so-called SNPs - Single Nucleotide Polymorphisms.

P
Proneuron Biotechnologies

Biopharmaceutical products for the of spinal cord injuries and other central nervous system disorders.

S
SpineAlign Medical

Spineworks Medical, Inc. designs and manufactures medical devices for spinal surgery.

Moximed Logo
Moximed

Moximed is a developer of unicompartmental load absorber implants for active patients with painful knee osteoarthritis (OA). The Moximed implants do not require bone cutting or bone removal, and, importantly, they absorb excess joint load rather than shift load to other areas of the joint. The company is based in Fremont, California.

I
Intrinsic Therapeutics

Intrinsic Therapeutics is a medical device company focused on delivering a safe treatment to improve outcomes in patients who are at a disproportionately high risk of requiring repeat surgeries due to reherniation following lumbar discectomy surgery.

H
Healionics

Healionics develops and manufactures STAR Biomaterials for implanted medical devices. The precisely controlled pore structure of the STAR technology induces an integrated healing response, overcoming fibrotic reactions and infection issues to enhance medical device performance and longevity.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.